Group One Trading
AKCA

Group One Trading’s Akcea Therapeutics Inc AKCA Stock Holding History

Group One Trading’s Portfolio AKCA Stock Details AKCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-100
Closed -$2K – 7333
2020
Q3 		$2K Sell
100
-7,900
-99% -$112K ﹤0.01% 5883
2020
Q2 		$110K Buy
+8,000
New +$123K ﹤0.01% 3835
2020
Q1 		– Sell
-13,000
Closed -$220K – 6033
2019
Q4 		$220K Buy
13,000
+12,100
+1,344% +$225K ﹤0.01% 3102
2019
Q3 		$14K Sell
900
-15,600
-95% -$332K ﹤0.01% 4499
2019
Q2 		$387K Sell
16,500
-11,000
-40% -$272K ﹤0.01% 2366
2019
Q1 		$779K Buy
27,500
+3,400
+14% +$99K 0.01% 1589
2018
Q4 		$726K Sell
24,100
-52,200
-68% -$1.46M 0.01% 1736
2018
Q3 		$2.67M Buy
76,300
+64,500
+547% +$1.95M 0.02% 949
2018
Q2 		$280K Sell
11,800
-6,100
-34% -$146K ﹤0.01% 2774
2018
Q1 		$458K Buy
+17,900
New +$385K ﹤0.01% 2133

Group One Trading's AKCA Position: Q4 2020 in Review

Group One Trading sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 12,800 shares — an estimated $232K sold.

Group One Trading first reported a position in AKCA in Q2 2019 and held it in 6 quarters. The position peaked at $234K in Q2 2019. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

  • Group One Trading reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
  • Group One Trading sold 12,800 Akcea Therapeutics Inc shares in Q4 2020, an estimated $232K.
  • Group One Trading first reported a position in Akcea Therapeutics Inc in Q2 2019 and held it in 6 quarters.
  • Group One Trading's Akcea Therapeutics Inc position peaked at $234K in Q2 2019.
  • 0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Group One Trading's 13F filing for Q4 2020, filed 10 Feb 2021.